* p ≤ 0.05
References:
1. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low
density lipoprotein cholesterol, ischaemic heart disease, and stroke:
systematic review and meta-analysis. BMJ. 2003;326(7404):1423.
2. Helin-Salmivaara A, Lavikainen P, Korhonen MJ, et al. Long-term
persistence with statin therapy: a nationwide register study in Finland.Clin Ther. 2008;30 Pt 2:2228-2240.
3. Lemstra M, Alsabbagh W. Proportion and risk indicators of
nonadherence to antihypertensive therapy: a meta-analysis. Patient
Preference and Adherence. 2014:211.
4. Evans CD, Eurich DT, Lamb DA, et al. Retrospective observational
assessment of statin adherence among subjects patronizing different
types of community pharmacies in Canada. J Manag Care Pharm.2009;15(6):476-484.
5. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J.
Long-term persistence in use of statin therapy in elderly patients.JAMA. 2002;288(4):455-461.
6. Sung JC, Nichol MB, Venturini F, Bailey KL, McCombs JS, Cody M.
Factors affecting patient compliance with antihyperlipidemic medications
in an HMO population. Am J Manag Care. 1998;4(10):1421-1430.
7. Aubert RE, Yao J, Xia F, Garavaglia SB. Is there a relationship
between early statin compliance and a reduction in healthcare
utilization? Am J Manag Care. 2010;16(6):459-466.
8. Guthrie RM. The effects of postal and telephone reminders on
compliance with pravastatin therapy in a national registry: results of
the first myocardial infarction risk reduction program. Clin
Ther. 2001;23(6):970-980.
9. World Health O. Adherence to long-term therapies : evidence for
action / [edited by Eduardo Sabaté]. In. Geneva: World Health
Organization; 2003.
10. Perreault S, Dragomir A, Blais L, et al. Impact of better adherence
to statin agents in the primary prevention of coronary artery disease.Eur J Clin Pharmacol. 2009;65(10):1013-1024.
11. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V.
Understanding patients’ adherence-related beliefs about medicines
prescribed for long-term conditions: a meta-analytic review of the
Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.
12. Corrao G, Conti V, Merlino L, Catapano AL, Mancia G. Results of a
retrospective database analysis of adherence to statin therapy and risk
of nonfatal ischemic heart disease in daily clinical practice in Italy.Clin Ther. 2010;32(2):300-310.
13. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of
medication adherence on hospitalization risk and healthcare cost.Med Care. 2005;43(6):521-530.
14. Brummel A, Carlson AM. Comprehensive Medication Management and
Medication Adherence for Chronic Conditions. Journal of Managed
Care & Specialty Pharmacy. 2016;22(1):56-62.
15. Deshpande S, Quek RG, Forbes CA, et al. A systematic review to
assess adherence and persistence with statins. Curr Med Res Opin.2017;33(4):769-778.
16. Fernandez-Lazaro CI, Garcia-Gonzalez JM, Adams DP, et al. Adherence
to treatment and related factors among patients with chronic conditions
in primary care: a cross-sectional study. BMC Fam Pract.2019;20(1):132.
17. Schedlbauer A, Schroeder K, Peters TJ, Fahey T. Interventions to
improve adherence to lipid lowering medication. Cochrane Database
Syst Rev. 2004(4):CD004371.
18. Stuurman-Bieze AG, Hiddink EG, van Boven JF, Vegter S. Proactive
pharmaceutical care interventions improve patients’ adherence to
lipid-lowering medication. Ann Pharmacother.2013;47(11):1448-1456.
19. Kamal AK, Khalid W, Muqeet A, et al. Making prescriptions ”talk” to
stroke and heart attack survivors to improve adherence: Results of a
randomized clinical trial (The Talking Rx Study). PLoS One.2018;13(12):e0197671.
20. Ofori-Asenso R, Jakhu A, Zomer E, et al. Adherence and Persistence
Among Statin Users Aged 65 Years and Over: A Systematic Review and
Meta-analysis. J Gerontol A Biol Sci Med Sci. 2018;73(6):813-819.
21. Chee YJ, Chan HH, Tan NC. Understanding patients’ perspective of
statin therapy: can we design a better approach to the management of
dyslipidaemia? A literature review. Singapore Med J.2014;55(8):416-421.
22. Warren JR, Falster MO, Tran B, Jorm L. Association of Continuity of
Primary Care and Statin Adherence. PLoS One.2015;10(10):e0140008.
23. van Houtum L, Heijmans M, Rijken M, Groenewegen P. Perceived quality
of chronic illness care is associated with self-management: Results of a
nationwide study in the Netherlands. Health Policy.2016;120(4):431-439.
24. Gardner AJ, Gray AL, Self S, Wagener JS. Strengthening care teams to
improve adherence in cystic fibrosis: a qualitative practice assessment
and quality improvement initiative. Patient Prefer Adherence.2017;11:761-767.
25. De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP Medication
Adherence Reporting Guideline (EMERGE). Ann Intern Med.2018;169(1):30-35.
26. Huiskes VJB, van den Ende CHM, van Dijk L, Burger DM, van den Bemt
BJF. Association between healthcare practitioners’ beliefs about statins
and patients’ beliefs and adherence. Br J Clin Pharmacol.2021;87(3):1082-1088.
27. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for
describing and defining adherence to medications. Br J Clin
Pharmacol. 2012;73(5):691-705.
28. de Bruin M, Viechtbauer W, Hospers HJ, Schaalma HP, Kok G. Standard
care quality determines treatment outcomes in control groups of
HAART-adherence intervention studies: implications for the
interpretation and comparison of intervention effects. Health
Psychol. 2009;28(6):668-674.
29. de Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers
HJ. Standard care impact on effects of highly active antiretroviral
therapy adherence interventions: A meta-analysis of randomized
controlled trials. Arch Intern Med. 2010;170(3):240-250.
30. Tommelein E, Mehuys E, Van Tongelen I, Brusselle G, Boussery K.
Accuracy of the Medication Adherence Report Scale (MARS-5) as a
quantitative measure of adherence to inhalation medication in patients
with COPD. Ann Pharmacother. 2014;48(5):589-595.
31. Salt E, Frazier SK. Predictors of Medication Adherence in Patients
with Rheumatoid Arthritis. Drug Dev Res. 2011;72(8):756-763.
32. Butler JA, Peveler RC, Roderick P, Horne R, Mason JC. Measuring
compliance with drug regimens after renal transplantation: comparison of
self-report and clinician rating with electronic monitoring.Transplantation. 2004;77(5):786-789.
33. Mardby AC, Akerlind I, Jorgensen T. Beliefs about medicines and
self-reported adherence among pharmacy clients. Patient Educ
Couns. 2007;69(1-3):158-164.
34. Nicklas LB, Dunbar M, Wild M. Adherence to pharmacological treatment
of non-malignant chronic pain: the role of illness perceptions and
medication beliefs. Psychol Health. 2010;25(5):601-615.
35. Sutton S, Kinmonth AL, Hardeman W, et al. Does electronic monitoring
influence adherence to medication? Randomized controlled trial of
measurement reactivity. Ann Behav Med. 2014;48(3):293-299.
36. Timmers L, Boons CC, Verbrugghe M, van den Bemt BJ, Van Hecke A,
Hugtenburg JG. Supporting adherence to oral anticancer agents: clinical
practice and clues to improve care provided by physicians, nurse
practitioners, nurses and pharmacists. BMC Cancer.2017;17(1):122.
37. Wouters H, Van Dijk L, Geers HC, et al. Understanding Statin
Non-Adherence: Knowing Which Perceptions and Experiences Matter to
Different Patients. PLoS One. 2016;11(1):e0146272.
38. Kooij MJ, Heerdink ER, van Dijk L, van Geffen EC, Belitser SV, Bouvy
ML. Effects of Telephone Counseling Intervention by Pharmacists (TelCIP)
on Medication Adherence; Results of a Cluster Randomized Trial.Front Pharmacol. 2016;7:269.
39. Berglund E, Lytsy P, Westerling R. Adherence to and beliefs in
lipid-lowering medical treatments: a structural equation modeling
approach including the necessity-concern framework. Patient Educ
Couns. 2013;91(1):105-112.